Home
>
US Stocks
>
GT Biopharma Inc
GT Biopharma Inc
GTBP

GT Biopharma Inc

$6.0722.28%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.15
Today Low/High
6.03 / 6.15
52 Week Low/High
$3.9 / $19.73
Market Cap
$178.32M

Company Details

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE™ NK cell engager platform. Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology.
Organisation
GT Biopharma Inc
Headquaters
Westlake Village, California, US
Employees
2.02K
Industry
Pharmaceuticals: Other
CEO
Anthony Cataldo

Discover more

Frequently Asked Questions

What is GT Biopharma Inc share price today

Can Indians buy GT Biopharma Inc shares?

How can I buy GT Biopharma Inc shares from India?

Can Fractional shares of GT Biopharma Inc be purchased?

What are the documents required to start investing in GT Biopharma Inc stocks?

We are a SEBI registered investement advisor